Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Miami
National Cancer Institute (NCI)